Atlas Trials

Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma

Clinical trial NCT06764355 · RECRUITING

Trial details

NCT number
NCT06764355
Sponsor
National Taiwan University Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
ESCCTotal Neoadjuvant TreatmentPathological Complete Response
Start date
2025-07-23
Primary completion
2027-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.